Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Anderson

Showing results (381-390 of 4,672) with videos related to

Pageof 468
Sort By:
Antiviral Research|June 6, 2012
Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tractPinar Iyidogan, Karen S Anderson
The American Journal of Pathology|December 1, 1990
Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibitionJ R Diamond, S Anderson
Antiviral Chemistry & Chemotherapy|June 8, 2013
Recent findings on the mechanisms involved in tenofovir resistancePinar Iyidogan, Karen S Anderson
The Biochemical Journal|January 15, 1986
Sequences encoding two trypsin inhibitors occur in strikingly similar genomic environmentsI B Kingston, S Anderson
Lancet (London, England)|April 26, 2026
Off-target benefits of influenza vaccination in cardiovascular disease - Authors' replyXin Du, Craig S Anderson
Oncotarget|March 14, 2019
HPV: Immunology lessons from an ancient oncotargetSri Krishna, Karen S Anderson
Current Biology : CB|July 1, 1996
RNA turnover: the helicase story unwindsJ S Anderson, R Parker
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1984
A new statistical procedure for testing equivalence in two-group comparative bioavailability trialsW W Hauck, S Anderson
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1983
Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probeS Anderson, I B Kingston
Vaccines|December 24, 2025
Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer VaccinesOlivia Roy, Karen S Anderson
Pageof 468

Showing results (381-390 of 4,672) with videos related to

Sort By:
Pageof 468
Antiviral Research|June 6, 2012
Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tractPinar Iyidogan, Karen S Anderson
The American Journal of Pathology|December 1, 1990
Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibitionJ R Diamond, S Anderson
Antiviral Chemistry & Chemotherapy|June 8, 2013
Recent findings on the mechanisms involved in tenofovir resistancePinar Iyidogan, Karen S Anderson
The Biochemical Journal|January 15, 1986
Sequences encoding two trypsin inhibitors occur in strikingly similar genomic environmentsI B Kingston, S Anderson
Lancet (London, England)|April 26, 2026
Off-target benefits of influenza vaccination in cardiovascular disease - Authors' replyXin Du, Craig S Anderson
Oncotarget|March 14, 2019
HPV: Immunology lessons from an ancient oncotargetSri Krishna, Karen S Anderson
Current Biology : CB|July 1, 1996
RNA turnover: the helicase story unwindsJ S Anderson, R Parker
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1984
A new statistical procedure for testing equivalence in two-group comparative bioavailability trialsW W Hauck, S Anderson
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1983
Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probeS Anderson, I B Kingston
Vaccines|December 24, 2025
Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer VaccinesOlivia Roy, Karen S Anderson
Pageof 468